Literature DB >> 19291421

Magnetic resonance imaging of persistent myocardial obstruction after myocardial infarction. A tool becoming increasingly important in clinical cardiology?

Leo H B Baur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291421     DOI: 10.1007/s10554-009-9453-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  11 in total

1.  Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.

Authors:  Saskia L M A Beeres; Jeroen J Bax; Theodorus A M Kaandorp; Katja Zeppenfeld; Hildo J Lamb; Petra Dibbets-Schneider; Marcel P M Stokkel; Willem E Fibbe; Albert de Roos; Ernst E van der Wall; Martin J Schalij; Douwe E Atsma
Journal:  Am J Cardiol       Date:  2006-03-20       Impact factor: 2.778

2.  Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction.

Authors:  Alexander Stork; Gunnar K Lund; Kai Muellerleile; Paul M Bansmann; Claus Nolte-Ernsting; Joern Kemper; Philipp G C Begemann; Gerhard Adam
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

3.  Novel application of breath-hold turbo spin-echo T2 MRI for detection of acute myocardial infarction.

Authors:  T H Lim; M K Hong; J S Lee; C W Mun; S J Park; S W Park; J S Ryu; J H Lee; D Chien; G Laub
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

4.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.

Authors:  K C Wu; E A Zerhouni; R M Judd; C H Lugo-Olivieri; L A Barouch; S P Schulman; R S Blumenthal; J A Lima
Journal:  Circulation       Date:  1998-03-03       Impact factor: 29.690

5.  Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion.

Authors:  D García-Dorado; J Oliveras; J Gili; E Sanz; F Pérez-Villa; J Barrabés; M J Carreras; J Solares; J Soler-Soler
Journal:  Cardiovasc Res       Date:  1993-08       Impact factor: 10.787

6.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms.

Authors:  J A Lima; R M Judd; A Bazille; S P Schulman; E Atalar; E A Zerhouni
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

7.  Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure.

Authors:  R B Jennings; J Schaper; M L Hill; C Steenbergen; K A Reimer
Journal:  Circ Res       Date:  1985-02       Impact factor: 17.367

8.  Investigation of T2-weighted signal intensity of infarcted myocardium and its correlation with delayed enhancement magnetic resonance imaging in a porcine model with reperfused acute myocardial infarction.

Authors:  Seong Hoon Choi; Joon-Won Kang; Sang-Tae Kim; Byung Han Lee; Eun Ju Chun; Karl H Schuleri; Sang Il Choi; Tae-Hwan Lim
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-28       Impact factor: 2.357

9.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; K F Browne; J Marco; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; N Chelliah; G C Timmis
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  1 in total

1.  T₂ -weighted MRI of post-infarct myocardial edema in mice.

Authors:  Ronald J Beyers; R Scott Smith; Yaqin Xu; Bryan A Piras; Michael Salerno; Stuart S Berr; Craig H Meyer; Christopher M Kramer; Brent A French; Frederick H Epstein
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.